Want to see HK:2157 full AI Analyst Report?
Lepu Biopharma Co. Ltd. Class H (2157) Income Statement
Lepu Biopharma Co. Ltd. Class H Income Statement
Last quarter (Q2 2026), Lepu Biopharma Co. Ltd. Class H's total revenue was $515.20M, an increase of 286.17% from the same quarter last year. In Q2, Lepu Biopharma Co. Ltd. Class H's net income was $27.01M. See Lepu Biopharma Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 910.67M | $ 367.79M | $ 225.35M | $ 15.57M | $ 0.00 | |
| $ 732.10M | $ 292.97M | $ 197.07M | $ 13.57M | $ -114.79M | |
| $ 644.67M | $ 683.74M | $ 192.28M | $ 718.05M | $ 1.01B | |
| Depreciation and Amortization | $ 91.30M | $ 100.18M | $ 102.57M | $ 95.45M | $ 95.25M |
| $ 178.73M | $ -295.67M | $ 86.95M | $ -596.53M | $ -848.43M | |
| $ 87.43M | $ -390.76M | $ 4.80M | $ -704.48M | $ -1.01B | |
| $ 166.46M | $ -33.43M | $ -35.10M | $ 5.04M | $ -19.23M | |
| $ 253.89M | $ -424.19M | $ -30.30M | $ -699.44M | $ -1.03B | |
| $ 254.60M | $ -411.38M | $ -22.10M | $ -689.05M | $ -1.01B | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.14 | $ -0.24 | $ -0.01 | $ -0.42 | $ -0.61 |
| Diluted EPS | $ 0.14 | $ -0.24 | $ -0.01 | $ -0.42 | $ -0.61 |
| Weighted Average Shares Outstanding | 1.76B | 1.69B | 1.66B | 1.64B | 1.66B |
| Weighted Average Shares Outstanding (Diluted) | 1.76B | 1.69B | 1.66B | 1.64B | 1.66B |
Currency in CNY
